Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02272855 |
| Title | A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Takara Bio Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Clinical Site | San Francisco | California | 94115 | United States | Details | |
| Clinical Site | Atlanta | Georgia | 30322 | United States | Details | |
| Clinical Site | Portland | Oregon | 97239 | United States | Details | |
| Clinical Site | Bethlehem | Pennsylvania | 18015 | United States | Details | |
| Clinical Site | Hershey | Pennsylvania | 17033 | United States | Details | |
| Clinical Site | Dallas | Texas | 75230 | United States | Details | |
| Clinical Site | Houston | Texas | 77030 | United States | Details | |
| Clinical Site | Salt Lake City | Utah | 84112 | United States | Details |